IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.91% | 45.74% | 44.09% | 19.82% | 21.93% |
| Total Depreciation and Amortization | -22.18% | -5.26% | 11.33% | 70.55% | 26.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,084.57% | -701.76% | -480.73% | 4.18% | -60.72% |
| Change in Net Operating Assets | 309.53% | 197.23% | 116.40% | 10.17% | 23.29% |
| Cash from Operations | 46.26% | 35.07% | 40.42% | 24.09% | 21.99% |
| Capital Expenditure | 89.13% | 82.76% | 85.67% | 75.77% | -27.78% |
| Sale of Property, Plant, and Equipment | -- | 783.33% | 1,216.67% | 1,216.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.53% | -35.63% | -51.44% | -33.19% | 2.51% |
| Cash from Investing | 425.00% | 6,725.00% | 684.91% | 413.13% | -7,300.00% |
| Total Debt Issued | -78.03% | -- | -- | -- | -- |
| Total Debt Repaid | 12.71% | -385.67% | -883.52% | -760.17% | -503.74% |
| Issuance of Common Stock | -20.91% | -21.52% | -60.39% | -67.96% | -0.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.94% | -64.35% | -39.20% | -45.11% | 49.16% |
| Foreign Exchange rate Adjustments | 212.50% | -125.00% | -55.00% | 64.29% | 87.69% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | 0.00% | 0.00% | 0.00% |
| Net Change in Cash | 54.43% | -95.73% | 52.21% | -65.70% | 76.08% |